F S&P 500
5,109.75 +18.25 (+0.36%) F Dow Jones
38,682.00 +300.00 (+0.78%) F Nasdaq
17,759.00 +109.25 (+0.62%) E-mini Russell 2000 Index Futur
2,023.90 -3.30 (-0.16%) Petróleo
79.20 +0.25 (+0.32%) Oro
2,308.60 -1.00 (-0.04%)
Exact Sciences Corporation (EXAS)
Fuera de horario:
Exact Sciences Corporation
5505 Endeavor Lane
Madison, WI 53719
United States
608 284 5700
https://www.exactsciences.com
Sector(es): Healthcare
Industria: Diagnostics & Research
Empleados a tiempo completo: 6,500
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Kevin T. Conroy | Chairman of The Board & CEO | 3.14M | N/D | 1966 |
| Mr. Jeffrey T. Elliott CFA | EVP & CFO | 1.13M | N/D | 1978 |
| Mr. Jake Orville MBA | Executive VP & General Manager of Pipeline | 1.04M | N/D | 1974 |
| Mr. Everett V. Cunningham | Chief Commercial Officer & Executive VP | 1.6M | N/D | 1966 |
| Mr. Brian Baranick | Executive VP & General Manager of Precision Oncology | 942.89k | N/D | 1978 |
| Dr. Jorge A. Garces Ph.D. | Chief Science Officer | N/D | N/D | 1972 |
| Mr. Nassar Nizami | Chief Information Officer | N/D | N/D | N/D |
| Ms. Megan Jones | Associate Manager of Investor Relations | N/D | N/D | N/D |
| Mr. Tim Caprez | Chief Compliance Counsel & VP | N/D | N/D | N/D |
| Mr. James Herriott | Senior VP, General Counsel & Secretary | N/D | N/D | 1980 |
Descripción
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Gestión corporativa
La calificación ISS Governance QuickScore de Exact Sciences Corporation a partir del 1 de mayo de 2024 es 4. Las puntuaciones principales son Auditoría: 1; Junta: 5; Derechos del accionista: 3; Compensación: 7.
